Related content

Synergistic effects of co-administration of angiotensin 1–7 and Neupogen on hematopoietic recovery in mice

By Ellefson Dolph   diZerega Gere   Espinoza Theresa   Roda Norma   Maldonado Sonia   Rodgers Kathleen  

Cancer Chemotherapy and Pharmacology, Vol. 53, Iss. 1, 2004-01 ,pp. : 15-24

Springer Publishing Company

Access to resources Recommend Favorite

Accelerated hematopoietic recovery with angiotensin-(1–7) after total body radiation

By Rodgers Kathleen E.   Espinoza Theresa   Roda Norma   Meeks Christopher J.   Hill Colin   Louie Stan G.   Dizerega Gere S.  

International Journal of Radiation Biology, Vol. 88, Iss. 6, 2012-06 ,pp. : 466-476

Informa Healthcare

Access to resources Recommend Favorite

The economics of febrile neutropenia: implications for the use of colony-stimulating factors

By Lyman G.H.   Kuderer N.   Greene J.   Balducci L.  

European Journal of Cancer, Vol. 34, Iss. 12, 1998-11 ,pp. : 1857-1864

Elsevier

Access to resources Recommend Favorite

Febrile neutropenia, colony-stimulating factors and therapy: time for a new methodology?

By Forrest Graeme   Schimpff Stephen   Cross Alan  

Supportive Care in Cancer, Vol. 10, Iss. 3, 2002-04 ,pp. : 177-180

Springer Publishing Company

Access to resources Recommend Favorite

Colony-stimulating factors for chemotherapy-related febrile neutropenia are associated with improved prognosis in adult acute lymphoblastic leukemia

By            

Molecular and Clinical Oncology, Vol. 3, Iss. 3, 2015-01 ,pp. : 730-736

Science Publishers

Access to resources Recommend Favorite